A San Diego doctor faces charges before the California medical board for several negligent acts in 2017 and 2018. The charges include failure to maintain adequate and accurate medical records and unprofessional conduct. Dr James Novak The accusation filed in May against James Novak, MD, involves two patients who received a controversial diabetes treatment at […]
Home »
Combo Provides ‘Broad Benefit’ Across NHL Subtypes
The combination of copanlisib plus rituximab led to a 48% reduction in the risk of disease progression or death, when compared with rituximab plus placebo in a phase 3 trial of patients with relapsed, indolent non-Hodgkin lymphoma (NHL). The trial, dubbed CHRONOS-3, is the first to report “a broad benefit” across histologic subtypes of relapsed, indolent […]
Vasodilatory Medications Found Protective Against Rosacea
Vasodilators may have a protective effect against rosacea, results from a single-center retrospective cohort study showed. “Our initial hypothesis was that perhaps antihypertensive agents might be associated with worsening rosacea,” one of the study authors, Jennifer G. Powers, MD, associate professor of dermatology at the University of Iowa, Iowa City, said in an interview. “What we […]
Type 2 Diabetes Linked to Increased Risk for Parkinson’s
New analyses of both observational and genetic data have provided “convincing evidence” that type 2 diabetes is associated with an increased risk for Parkinson’s disease. Dr Alastair Noyce “The fact that we see the same effects in both types of analysis separately makes it more likely that these results are real — that type 2 […]